Ojjaara Momelotinib — United Healthcare
9 indications indexed for this drug.
- Accelerated Blast Phase Myeloproliferative NeoplasmView coverage criteria
- Accelerated Blast Phase Myeloproliferative NeoplasmsView coverage criteria
- Higher Risk MyelofibrosisView coverage criteria
- Intermediate Or High Risk Myelofibrosis MfView coverage criteria
- Lower Risk MyelofibrosisView coverage criteria
- Myelofibrosis Associated AnemiaView coverage criteria
- Myeloproliferative NeoplasmsView coverage criteria
- Primary MyelofibrosisView coverage criteria
- Secondary Myelofibrosis Post Polycythemia Vera Pv And Post EView coverage criteria